Navigation Links
Instrumentation Laboratory Announces Contract for Multi-Parameter Testing Products with Broadlane
Date:7/24/2008

LEXINGTON, Mass., July 24 /PRNewswire/ -- Instrumentation Laboratory (IL) today announced that Broadlane, Inc., a leading supply chain services company, has awarded the Company with a five-year contract covering its critical care products and services. Broadlane, based in Dallas, TX, counts among its clients more than 915 acute care hospitals, more than 2,600 sub-acute care facilities and more than 18,000 physician practices.

The contract covers IL's portfolio of critical care analyzers, reagents, consumables and service, including IL's flagship products, the new GEM(R) Premier(TM) 4000 and the GEM Premier 3000 analyzers for blood gas, electrolyte and metabolite testing, new GEMweb(R) Plus information management system for the GEM analyzers, GEM PCL Plus, a portable coagulation analyzer and GEM OPL, a portable CO-Oximeter.

"Broadlane's selection of our critical care product line is a testament to the flexibility offered by the GEM Premier 4000 analyzer," said Brian Durkin, Director of Sales and National Accounts at IL. "This instrument is far more than a blood gas analyzer and we look forward to adding an even broader spectrum of testing to the GEM Premier 4000 in the future."

The GEM Premier 4000 is a revolutionary blood gas analyzer, with integrated CO-Oximetry, that quickly provides consistent, accurate, lab-quality results throughout the hospital. Self-contained cartridges incorporate all components for patient testing and are maintenance-free. Onboard Intelligent Quality Management (iQM(R))automates quality control and continuously detects, corrects and documents to assure quality results and compliance, 24/7, regardless of operator or testing location.

iQM, coupled with its cartridge-based technology and ease of use, allows the GEM Premier analyzers to be used throughout the hospital, at the point of care and in the lab. The flexibility of the many cartridge sizes and menus makes the GEM Premier analyzers ideally suited to meet the needs of the diverse hospital market.

Instrumentation Laboratory (http://www.ilus.com), founded in 1959, is a worldwide developer, manufacturer and distributor of in vitro diagnostic instruments, related reagents and controls for use primarily in hospitals and independent clinical laboratories. The company's product lines include critical care systems, hemostasis systems and information management systems. IL's GEM product offerings, part of the critical care line, include the new GEM Premier 4000 analyzer with Intelligent Quality Management (iQM(R)), GEM Premier 3000 analyzer, GEM OPL(TM), a portable whole blood CO-Oximeter and the GEM PCL Plus, a portable coagulation analyzer. IL's hemostasis portfolio includes the ACL TOP(R) Family of Hemostasis Testing Systems, fully automated, high-productivity analyzers, including the ACL TOP and the new ACL TOP 500 CTS. IL also offers the ACL ELITE(R) and ELITE PRO, other hemostasis analyzers and the HemosIL(R) line of reagents. IL is based in Lexington, Massachusetts.


'/>"/>
SOURCE Instrumentation Laboratory
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Instrumentation Laboratory to Celebrate 50th Anniversary With 50 and Forward Program
2. Instrumentation Laboratory Ships 1000th GEM Premier 4000 Analyzer to Scripps Health
3. Cepheid and Instrumentation Laboratory Introduce Xpert(TM) HemosIL(R) FII & FV Assay to European Clinical Testing Market
4. HealthTrust Expands Contract With Instrumentation Laboratory for Critical Care Portfolio to Include Consorta
5. Thermo Fisher Scientific Selected by China Doping Control Center to Supply Testing Instrumentation for the 2008 Olympic Games in Beijing
6. Instrumentation Laboratory Receives FDA Clearance to Expand the Intended Use for HemosIL(R) D-Dimer HS Assay
7. Alliance for Medical Devices, Instrumentation and Diagnostics formed between Fraunhofer Center for Manufacturing Innovation and Boston University
8. A New President at the Head of the Genethon Laboratory
9. M. D. Anderson Automates Laboratory Workflow with Stone Bond Technologies : EE-LIMS™ from Stone Bond Technologies Will Document Activities within the Laboratory Workflow at the siRNA Facility, Increasing Throughput, While Reducing Risks
10. U.S. Commerce Secretary Gutierrez Cuts Ribbon on MaxWell Biocorporations New Pharmaceutical Development Center and Quality Control Laboratory in Ukraine
11. Introducing Laboratory Evaluations for Integrative and Functional Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... Dutch philosopher Koert van Mensvoort - founder of the Next Nature ... Eindhoven - has written a ,Letter to Humanity, in support of ... becoming a slave and victim to its own technology, but to employ technology ... ... Mensvoort – founder of the Next Nature Network and Fellow of ‘Next Nature’ ...
(Date:4/20/2017)... , April 20, 2017 For ... focuses on novel drug development and clinical research aimed at ... Biostage Inc. (NASDAQ: BSTG), Keryx Biopharmaceuticals Inc. (NASDAQ: KERX), Kite ... ZIOP ). You can access our complimentary research reports ... ...
(Date:4/19/2017)... ... April 18, 2017 , ... A number of new instruments ... which is part of the Protein and Cell Analysis Education Webinar Series , ... this technology fits in current and future applications. , Many flow cytometers have ...
(Date:4/19/2017)... (PRWEB) , ... April 18, 2017 , ... ... Halo Labs . The move comes after the company changed focus to ... market, our new brand and our new technology,” says CEO Robert Hart. Founders ...
Breaking Biology Technology:
(Date:4/5/2017)... 2017 Today HYPR Corp. , leading ... component of the HYPR platform is officially FIDO® ... security architecture that empowers biometric authentication across Fortune 500 ... secured over 15 million users across the financial services ... home product suites and physical access represent a growing ...
(Date:4/3/2017)... April 3, 2017  Data captured by ... platform, detected a statistically significant association between ... to treatment and objective response of cancer ... to predict whether cancer patients will respond ... as well as to improve both pre-infusion potency ...
(Date:3/30/2017)... NEW YORK , March 30, 2017 ... by type (physiological and behavioral), by technology (fingerprint, AFIS, ... recognition, voice recognition, and others), by end use industry ... travel and immigration, financial and banking, and others), and ... Europe , Asia Pacific ...
Breaking Biology News(10 mins):